» Articles » PMID: 37688635

Performance and Mechanism of Co-culture of Monascus Purpureus, Lacticaseibacillus Casei, and Saccharomyces Cerevisiae to Enhance Lovastatin Production and Lipid-lowering Effects

Overview
Date 2023 Sep 9
PMID 37688635
Authors
Affiliations
Soon will be listed here.
Abstract

To facilitate lipid-lowering effects, a lovastatin-producing microbial co-culture system (LPMCS) was constituted with a novel strain Monascus purpureus R5 in combination with Lacticaseibacillus casei S5 and Saccharomyces cerevisiae J7, which increased lovastatin production by 54.21% compared with the single strain R5. Response Surface Methodology (RSM) optimization indicated lovastatin yield peaked at 7.43 mg/g with a fermentation time of 13.88 d, water content of 50.5%, and inoculum ratio of 10.27%. Meanwhile, lovastatin in LPMCS co-fermentation extracts (LFE) was qualitatively and quantitatively analyzed by Thin-Layer Chromatography (TLC) and High-Performance Liquid Chromatography (HPLC). Cellular experiments demonstrated that LFE exhibited no obvious cytotoxicity to L-02 cells and exhibited excellent biosafety. Most notably, high-dose LFE (100 mg/L) exhibited the highest reduction of lipid accumulation, total cholesterol, and triglycerides simultaneously in oleic acid-induced L-02 cells, which decreased by 71.59%, 38.64%, and 58.85% than untreated cells, respectively. Overall, LPMCS provides a potential approach to upgrade the lipid-lowering activity of Monascus-fermented products with higher health-beneficial effects.

References
1.
Wang J, Zhao J, Yan C, Xi C, Wu C, Zhao J . Identification and evaluation of a lipid-lowering small compound in preclinical models and in a Phase I trial. Cell Metab. 2022; 34(5):667-680.e6. DOI: 10.1016/j.cmet.2022.03.006. View

2.
Li H, Liang J, Han M, Wang X, Ren Y, Wang Y . Sequentially fermented dealcoholized apple juice intervenes fatty liver induced by high-fat diets via modulation of intestinal flora and gene pathways. Food Res Int. 2022; 156:111180. DOI: 10.1016/j.foodres.2022.111180. View

3.
Corpier C, Jones P, Suki W, Lederer E, Quinones M, Schmidt S . Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients. JAMA. 1988; 260(2):239-41. View

4.
Patel S . Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons. World J Microbiol Biotechnol. 2016; 32(5):87. DOI: 10.1007/s11274-016-2035-2. View

5.
Huang Y, Li P, Du T, Du X, Wang S . Protective effect and mechanism of Monascus-fermented red yeast rice against colitis caused by Salmonella enterica serotype Typhimurium ATCC 14028. Food Funct. 2020; 11(7):6363-6375. DOI: 10.1039/d0fo01017k. View